Invest In The Healthspan Catalyst Fund

The Healthspan Catalyst Fund is an invitation to be part of a seismic shift in global health—one that targets inflammation at its root, the biological driver behind over 80% of chronic diseases. From heart disease and cancer to addiction, pain, and neurodegeneration, unchecked inflammation erodes not only human vitality, but also the sustainability of our healthcare systems.

Sen-Jam Pharmaceuticals is leading a revolution in inflammatory care. Their proprietary platform approach combines decades of scientific insight with speed-to-market regulatory strategy, enabling them to rapidly develop and deliver small-molecule therapeutics that are safe, effective, and globally scalable. By leveraging proven, repurposed active pharmaceutical ingredients with novel combinations and delivery systems, Sen-Jam dramatically reduces cost, development risk, and time—unlocking high-impact solutions with extraordinary public health potential.

What sets Sen-Jam apart is their commitment to democratizing access to advanced care. They are not building single-drug success stories—they are building a sustainable, repeatable engine for healthspan innovation. From over-the-counter opioid-sparing pain relievers to oral COVID therapeutics and alcohol use disorder solutions, Sen-Jam's pipeline addresses some of the most urgent and under-served conditions of our time.

For donor-advised fund participants, this is more than an investment—it is a legacy play. A way to catalyze systems-level change in global health equity, while supporting a mission-first enterprise built on scientific rigor, regulatory fluency, and ethical commercialization. The Healthspan Catalyst Fund allows philanthropically aligned capital to play an active role in rewriting the future of aging, vitality, and global wellness.

Join Sen-Jam in transforming sick care into healthspan care—for all.